There is one open-label intravenous safety pilot in two healthy adults, who received single doses of 10 mg and 20 mg with no comparator, no blinding, and short-term observation limited to vital signs, self reported symptoms and labs across two days [4]
By dampening the intensity of the brain's reward response, these medications may help blunt the urge to chase immediate gratification from substances like alcohol, nicotine, or stimulants." Dr Sophie Dix, Head of Medical Product and Content at Levity "What we're likely seeing is a neurochemical dampening of the 'reward high' that drives many compulsive behaviors
Despite the countless creams, lotions, and potions marketed as miracle cures for eczema, the reality is that this condition isn't just a simple skin issue
The study also linked other genes to an increase in adverse events